Abstract
Objective
This study aimed to compare the clinical characteristics and survival differences between early-onset colorectal cancer (EOCRC) patients and late-onset colorectal cancer (LOCRC) patients, identify the risk factors for cancer-specific mortality (CSM) in LOCRC patients and construct a mortality risk assessment nomogram.
Methods
CRC patients diagnosed pathologically between 2010 and 2019 in the SEER database were included and divided into the early-onset group and the late-onset group, and the late-onset group was divided into the training and validation sets. The Fine-Gray competing risk model was applied to analyze the prognostic factors of LOCRC patients and establish a competing risk nomogram for CSM.
Results
There are differences in the distribution of multiple clinical features between the early-onset group and the late-onset group. Age, tumor size, histological type, pathological grading, T stage, N stage, M stage, SEER stage, primary tumor surgery, metastatic lesion surgery, radiotherapy, chemotherapy, neural invasion, and carcinoembryonic antigen (CEA) were independent influencing factors of the CSM rate in LOCRC patients. The C-index of the prognosis model outweighed 0.8, and the calibration curves fitted the reference line well.
Conclusion
The CSM competing risk nomogram for LOCRC patients in this study had acceptable predictive performance that could be applied to the clinic.
Similar content being viewed by others
Data availability
Publicly available datasets were analyzed in this study. These data were derived from the SEER database.
References
Cavestro GM, Mannucci A, Zuppardo RA, Di Leo M, Stoffel E, Tonon G (2018) Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features. Dig Liver Dis 50(6):521–532
Chen F, Wang F, Bailey CE, Murff HJ, Berlin JD, Shu XO et al (2020) Evaluation of determinants for age disparities in the survival improvement of colon cancer: results from a cohort of more than 486,000 patients in the United States. Am J Cancer Res 10(10):3395–3405
Chen Y, Chen Z, Huang J, Hu J, He X, Lan P et al (2022) Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location. Int J Clin Oncol 27(4):749–755
Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A (2022) Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin 72(4):372–401
Collaborative R, Zaborowski AM, Abdile A, Adamina M, Aigner F, d’Allens L et al (2021) Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg 156(9):865–874
Driedger MR, Cleary SP, Nagorney DM (2021) Synchronous colorectal liver metastases: therapeutic considerations. Hepatobiliary Surg Nutr 10(5):711–713
Eng C, Jacome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN et al (2022) A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol 23(3):e116–e128
Gausman V, Dornblaser D, Anand S, Hayes RB, O’Connell K, Du M et al (2020) Risk factors associated with early-onset colorectal cancer. Clin Gastroenterol Hepatol 18(12):2752–2759
Gogenur I, Qvortrup C (2021) Colorectal cancer screening in Europe: what are the next steps? Lancet Oncol 22(7):898–899
Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC et al (2021) Clinical characteristics and outcomes of colorectal cancer in the ColoCare study: differences by age of onset. Cancers (Basel) 13(15):3817
Kibriya MG, Raza M, Quinn A, Kamal M, Ahsan H, Jasmine F (2022) A transcriptome and methylome study comparing tissues of early and late onset colorectal carcinoma. Int J Mol Sci 23(22):14261
Killock D (2023) Early MRD predicts disease recurrence and benefit from adjuvant chemotherapy in CRC. Nat Rev Clin Oncol 20(3):137
Kulik U, Plohmann-Meyer M, Gwiasda J, Kolb J, Meyer D, Kaltenborn A et al (2018) Proposal of two prognostic models for the prediction of 10-year survival after liver resection for colorectal metastases. HPB Surg 2018:5618581
Liu C, Wang T, Yang J, Zhang J, Wei S, Guo Y et al (2022) Distant metastasis pattern and prognostic prediction model of colorectal cancer patients based on big data mining. Front Oncol 12:878805
Livingstone SJ, Guthrie B, Donnan PT, Thompson A, Morales DR (2022) Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. BMC Med 20(1):152
Manjelievskaia J, Brown D, McGlynn KA, Anderson W, Shriver CD, Zhu K (2017) Chemotherapy use and survival among young and middle-aged patients with colon cancer. JAMA Surg 152(5):452–459
McClelland PH, Liu T, Ozuner G (2022) Early-onset colorectal cancer in patients under 50 years of age: demographics, disease characteristics, and survival. Clin Colorectal Cancer 21(2):e135–e144
Provenzale D, Ness RM, Llor X, Weiss JM, Abbadessa B, Cooper G et al (2020) NCCN guidelines insights: colorectal cancer screening, version 2.2020. J Natl Compr Canc Netw 18(10):1312–1320
Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S et al (2014) Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis. Eur J Prev Cardiol 21(1):74–80
Rodriguez L, Brennan K, Karim S, Nanji S, Patel SV, Booth CM (2018) Disease characteristics, clinical management, and outcomes of young patients with colon cancer: a population-based study. Clin Colorectal Cancer 17(4):e651–e661
Shen Y, Qi Y, Wang C, Wu C, Zhan X (2023) Predicting specific mortality from laryngeal cancer based on competing risk model: a retrospective analysis based on the SEER database. Ann Transl Med 11(4):179
Stoffel EM, Murphy CC (2020) Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology 158(2):341–353
Tai Q, Xue W, Li M, Zhuo S, Zhang H, Fang F et al (2022) Survival nomogram for metastasis colon cancer patients based on SEER database. Front Genet 13:832060
Tilg H, Adolph TE, Gerner RR, Moschen AR (2018) The intestinal microbiota in colorectal cancer. Cancer Cell 33(6):954–964
Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14(10):101174
Yamashita R, Long J, Longacre T, Peng L, Berry G, Martin B et al (2021) Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study. Lancet Oncol 22(1):132–141
Acknowledgements
The authors thank the NCI for providing the SEER dataset.
Funding
The Tianjin Municipal Education Commission Scientific Research Program (Natural Science) of China (No.2019KJ048) funded this study.
Author information
Authors and Affiliations
Contributions
Conception and design: ZL and YD. Administrative support: JxZ, JlZ and RX. Collection and assembly of data: ZL and YD. Data analysis and interpretation: ZL. Manuscript writing: all authors. Final approval of manuscript: all authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liao, Z., Deng, Y., Zhou, J. et al. A competing risk nomogram to predict cancer-specific mortality of patients with late-onset colorectal cancer. J Cancer Res Clin Oncol 149, 14025–14033 (2023). https://doi.org/10.1007/s00432-023-05069-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-05069-3